Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular double-stranded DNA (dsDNA) is the fundamental molecule that stores and transmits genetic information within the nucleus and mitochondria of eukaryotic cells (Nature Education, 2014). It consists of two polynucleotide chains coiled around each other to form a double helix, stabilized by hydrogen bonds between complementary nitrogenous bases. As a therapeutic target, dsDNA is primarily exploited in cancer treatment through the use of cytotoxic agents that induce structural damage, such as alkylating agents, cross-linkers, and intercalators (National Cancer Institute, 2023). These interactions interfere with essential processes like DNA replication and transcription, leading to cell cycle arrest and programmed cell death (StatPearls, 2023). Additionally, dsDNA acts as a potent damage-associated molecular pattern (DAMP) when released into the cytosol, triggering innate immune responses via the cGAS-STING pathway (PubMed, 2020). In autoimmune conditions like systemic lupus erythematosus (SLE), dsDNA is a major autoantigen, and the presence of anti-dsDNA antibodies is a hallmark diagnostic marker (Mayo Clinic, 2023). While effective, targeting dsDNA often lacks specificity for cancer cells, leading to significant side effects such as bone marrow suppression and the risk of secondary cancers (American Cancer Society, 2022).
DNA alkylation, DNA intercalation, DNA cross-linking, DNA strand breakage, and minor groove binding.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular double-stranded DNA (dsDNA) (dsDNA).